(NASDAQ: OCUL) OCULAR THERAPEUTIX Building a new strategic in ophthalmology May 2023 FORWARD LOOKING STATEMENTS Any statements in this presentation about future expectations, plans, and prospects for the Company, including the commercialization of DEXTENZA® or any of the Company’s productsorproductcandidates;thedevelopmentandregulatorystatusoftheCompany’sproductcandidates,suchastheCompany’sdevelopmentof,timingof,andprospectsfor approvability of OTX-TKI forthetreatment of retinal diseases including wet AMD a ...